159 related articles for article (PubMed ID: 21145798)
1. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
Bureau C; Métivier S; D'Amico M; Péron JM; Otal P; Pagan JC; Chabbert V; Chagneau-Derrode C; Procopet B; Rousseau H; Bosch J; Vinel JP
J Hepatol; 2011 May; 54(5):901-7. PubMed ID: 21145798
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
4. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
5. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
9. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
10. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
12. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
Papp M; Mezei G; Udvardy M; Altorjay I
Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
[TBL] [Abstract][Full Text] [Related]
13. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
[TBL] [Abstract][Full Text] [Related]
15. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
[TBL] [Abstract][Full Text] [Related]
16. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
19. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
Salerno F; Cammà C; Enea M; Rössle M; Wong F
Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
